Myopia Treatment Market Intelligence Report Covers Trends, Segments And Regional Growth

The myopia treatment market is on track for significant expansion in the coming years, driven by advances in therapies and growing awareness among patients and healthcare providers. As more people seek effective ways to manage and control myopia, the industry is responding with innovative technologies and a broadening range of treatment options.

Forecasted Market Growth and Size for Myopia Treatment by 2030
The myopia treatment market is projected to reach a value of $30.38 billion by 2030, growing at a compound annual growth rate (CAGR) of 9.2%. This rapid expansion is fueled by increasing recognition of myopia control methods, advancements in laser treatment technologies, and surging demand for orthokeratology. Additionally, heightened investment in ophthalmic research and the wider adoption of cutting-edge diagnostic tools are fostering the market's growth. Key trends shaping this period include a stronger preference for minimally invasive refractive surgeries, increased use of myopia control lenses specifically for children, a rise in digital eye strain-related myopia cases, and the spread of preventive eye care awareness programs globally.

The myopia treatment market size has grown strongly in recent years. It will grow from $19.52 billion in 2025 to $21.38 billion in 2026 at a compound annual growth rate (CAGR) of 9.5%. The growth in the historic period can be attributed to increasing screen time exposure, rise in childhood myopia prevalence, limited access to preventive eye care, early development of refractive surgery techniques, initial adoption of corrective eyewear solutions.

Download a free sample of the myopia treatment market report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=20892&type=smp&utm_source=OpenPR&utm_medium=Paid&utm_campaign=Aug_PR

Key Companies Leading the Myopia Treatment Industry
Several prominent players are at the forefront of the myopia treatment market, including Regeneron Pharmaceuticals Inc., Alcon Inc., Bausch Health Companies Inc., Hoya Corporation, Johnson & Johnson Vision Care Inc., CooperVision Inc., Menicon Co. Ltd., Topcon Healthcare Inc., Essilor Ltd., NIDEK CO. LTD., SightGlass Vision Inc., SCHWIND eye-tech-solutions GmbH, Visioneering Technologies Inc., MEDMONT INTERNATIONAL PTY LTD., Vyluma Inc., Haag-Streit Holding AG, NovaSight Ltd., Euclid Vision Corporation, Treehouse Eyes LLC, Sydnexis Inc., Neurobit Technologies Co. Ltd., and Kubota Pharmaceutical Holdings Co. Ltd.

A notable development in this market occurred in January 2023 when CooperVision, Inc., a US-based maker of soft contact lenses, acquired SynergEyes, Inc. This strategic move strengthens CooperVision's portfolio in specialty contact lenses designed to slow myopia progression, boosting its influence in advanced eye care solutions.

View the full myopia treatment market report:
https://www.thebusinessresearchcompany.com/report/myopia-treatment-global-market-report?utm_source=OpenPR&utm_medium=Paid&utm_campaign=Aug_PR

Emerging Trends Focusing on Advanced Diagnostics in Myopia Treatment
Companies within the myopia treatment market are increasingly investing in advanced diagnostic devices such as optical biometers to improve treatment accuracy and personalization. Optical biometers use light-based technology to measure critical eye parameters, including axial length and corneal curvature, which are essential for diagnosing and monitoring myopia progression.

For example, in February 2023, NIDEK Co., Ltd., a Japanese ophthalmic equipment manufacturer, launched the AL-Scan M and MV-1 devices. The AL-Scan M features 3D auto-tracking and auto-shot functions that facilitate quick, easy measurements akin to those from an autorefractor, enhancing patient throughput-especially for children. The device provides precise axial length measurements, crucial for tracking myopia. It also integrates with the MV-1 Myopia Viewer software, which aids in monitoring treatment history and patient compliance.

Detailed Breakdown of the Myopia Treatment Market Segments
The myopia treatment market is categorized into several segments to better understand its structure:
1) By Type: Simple Myopia, High Myopia, Pathological Myopia
2) By Treatment Method: Eyeglasses, Contact Lenses, Refractive Surgery, Laser-Assisted In Situ Keratomileusis (LASIK), Photorefractive Keratectomy (PRK), Orthokeratology (Ortho-K)
3) By Route of Administration: Oral, Parenteral, Other Routes
4) By Distribution Channel: Direct Tender, Retail Sales, Other Channels
5) By End-User: Physician Offices, Reference Laboratories, Other End-Users

Further subdivisions include:
- Simple Myopia: Mild and Moderate levels
- High Myopia: Severe and Very Severe categories
- Pathological Myopia: Degenerative and Malignant forms

This segmentation provides a clear view of the various treatment approaches and patient categories addressed within the market, offering insight into how the industry targets different needs and preferences.

Our latest 2026 market reports provide expanded strategic and visual intelligence with market attractiveness scoring and analysis, total addressable market (TAM) analysis, company scoring matrix graphics and tables, Excel-based forecasting dashboards, market hotspots infographics, key technologies and future trend analysis, together with updated graphics and tables.

Reach out to us:
The Business Research Company: https://www.thebusinessresearchcompany.com/,
Americas +1 310-496-7795,
Europe +44 7882 955267,
Asia & Others +44 7882 955267 & +91 8897263534,
Email us at info@tbrc.info.

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Learn More About The Business Research Company
With over 17500+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.Our flagship product, the Global Market Model (GMM), is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.